Nicole Lambert
Directeur/Bestuurslid bij ARCUS BIOSCIENCES, INC.
Vermogen: 5 M $ op 31-05-2024
Oorsprong van het eerstegraads netwerk van Nicole Lambert
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
| Public Company | Biotechnology | 27 | |
Myriad Genetic Laboratories, Inc.
 Myriad Genetic Laboratories, Inc. Miscellaneous Commercial ServicesCommercial Services Myriad Genetic Laboratories, Inc. provides cancer predisposition testing services. It operates as a biopharmaceutical company that focuses on developing therapeutic and predictive medicine products. The company was founded on October 11, 1995 and is headquartered in Salt Lake City, UT.
1
| Subsidiary | Miscellaneous Commercial Services | 1 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Nicole Lambert via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Director of Finance/CFO Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| GILEAD SCIENCES, INC. | Biotechnology | Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal | |
Duke University
 Duke University Other Consumer ServicesConsumer Services Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC. | College/University | Graduate Degree Undergraduate Degree Doctorate Degree | |
| UNITY BIOTECHNOLOGY, INC. | Biotechnology | Director/Board Member Director of Finance/CFO Comptroller/Controller/Auditor | |
PACT Pharma, Inc.
 PACT Pharma, Inc. Pharmaceuticals: MajorHealth Technology PACT Pharma, Inc. develops pharmaceutical products. It offers personalizes adoptive cell therapies with neoantigen-targeted T cells against cancer. The company is headquartered in South San Francisco, CA. | Pharmaceuticals: Major | Founder Founder Founder | |
| RAPT THERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Executive Officer President Chief Tech/Sci/R&D Officer | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| MEDIVATION INC | Pharmaceuticals: Major | Founder Director/Board Member Director of Finance/CFO | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| University of California, Los Angeles | College/University | Undergraduate Degree Corporate Officer/Principal | |
| University of Michigan | College/University | Undergraduate Degree Doctorate Degree | |
Axovant Sciences, Inc.
 Axovant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Part of Sio Gene Therapies, Inc., Axovant Sciences, Inc. is a company that manufactures and distributes pharmaceutical products. The company is based in New York, NY. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| CHEMOCENTRYX, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Human Resources Officer | |
| University of California, Berkeley | College/University | Doctorate Degree Undergraduate Degree | |
Ysios Capital Partners SGEIC SA
 Ysios Capital Partners SGEIC SA Investment ManagersFinance Ysios Capital Partners SGEIC SA (Ysios Capital) is a venture capital firm founded in 2007 by Joël Jean Pierre Jean-Mairet, Julia Salaverría Monfort and Josep Lluís Sanfeliu Benet. The firm is headquartered in San Sabastian, Spain with additional office in Barcelona. | Investment Managers | Private Equity Investor Private Equity Investor | |
| CITIGROUP INC. | Major Banks | Corporate Officer/Principal | |
| Dartmouth College | College/University | Undergraduate Degree | |
Inbiomotion SL
 Inbiomotion SL Medical SpecialtiesHealth Technology Inbiomotion SL designs and develops diagnostic assays. It focus on genetic biomarkers, which predict the bone-specific metastases in cancer patients. The firm develops biomarker in breast cancer primary tumors for predicting the bone relapse. The company was founded by in 2010 and is headquartered in Barcelona, Spain. | Medical Specialties | Director/Board Member | |
| ATRECA, INC. | Biotechnology | Director/Board Member | |
| NURIX THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| Duke University School of Medicine | College/University | Doctorate Degree | |
Rainier Therapeutics, Inc.
 Rainier Therapeutics, Inc. BiotechnologyHealth Technology Rainier Therapeutics, Inc. operates as a biotechnology company that develops a targeted biologic for the potential treatment of metastatic bladder cancer. It provides Vofatamab, an antibody that is focused on the fibroblast growth factor of bladder and other cancer. The company was founded by Stephen Lau and is headquartered in San Leandro, CA. | Biotechnology | Director/Board Member | |
Jewish Hospital
 Jewish Hospital Hospital/Nursing ManagementHealth Services Part of Community Health Systems, Inc., Jewish Hospital is a hospital. The company is based in Cincinnati, OH. Jewish Hospital was acquired by Mercy Health Partners, Inc. (Pennsylvania), a NPO of Community Health Systems, Inc. from Jewish Foundation of Cincinnati on March 01, 2010 for $180 million. | Hospital/Nursing Management | Corporate Officer/Principal | |
| CYTOMX THERAPEUTICS, INC. | Pharmaceuticals: Major | Director of Finance/CFO | |
| UCLA Anderson School of Management | College/University | Masters Business Admin | |
| Goizueta Business School-Emory | College/University | Undergraduate Degree | |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Pharmaceuticals: Major | Director of Finance/CFO | |
| The College of William & Mary | College/University | Undergraduate Degree | |
| DNIB UNWIND INC | Biotechnology | Chief Tech/Sci/R&D Officer | |
| The University of Colorado School of Medicine | College/University | Doctorate Degree | |
| The University of Colorado | College/University | Undergraduate Degree | |
Transcelerate Biopharma, Inc.
 Transcelerate Biopharma, Inc. BiotechnologyHealth Technology Transcelerate Biopharma, Inc. is a non-profit consortium that collaborates with pharmaceutical and biotechnology companies to improve the delivery of new medicines. The non-profit company is based in King of Prussia, PA. The organization's mission is to identify, prioritize, design, and facilitate implementation of solutions to drive the efficient, effective, and high-quality delivery of new medicines. Transcelerate has 20 member companies and 30+ initiatives focused on improving the patient and site experience, enhancing sponsor efficiencies and drug safety, and harmonizing processes and sharing information. The company was founded by Garry Arthur Neil, and Janice Chang has been the CEO of the company since 2014. | Biotechnology | Director/Board Member | |
Hexagon Bio, Inc.
 Hexagon Bio, Inc. BiotechnologyHealth Technology Hexagon Bio, Inc. operates as a data-driven biotechnology company. It engages in mining of fungal genome data for drugs. The company was founded by Maureen E. Hillenmeyer, Brian T. Naughton, Colin James Bell Harvey and Yi Tang and is headquartered in Menlo Park, CA. | Biotechnology | Director/Board Member | |
Shasqi, Inc.
 Shasqi, Inc. Pharmaceuticals: MajorHealth Technology Shasqi, Inc. operates as a biopharmaceutical company. It develops novel chemistry to optimize the healing power of modern medicine. The company was founded by Jose M. Mejia Oneto and is headquartered in San Francisco, CA. | Pharmaceuticals: Major | Director/Board Member | |
| SAGIMET BIOSCIENCES INC. | Pharmaceuticals: Major | Director/Board Member | |
| University of Maryland | College/University | Doctorate Degree | |
Roche Group
 Roche Group Real Estate DevelopmentFinance Roche Group manages real estate properties. The company designs, develops and constructs residential, commercial and industrial properties. It also provides property management services. The company is headquartered in Basel, Switzerland. | Real Estate Development | Corporate Officer/Principal | |
| REGENERON PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Sumitomo Pharma America, Inc.
 Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 1984 and is headquartered in Marlborough, MA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| New York University School of Medicine | College/University | Corporate Officer/Principal | |
| University of California | College/University | Corporate Officer/Principal | |
| ARGENX SE | Pharmaceuticals: Other | Director/Board Member | |
| Jonsson Comprehensive Cancer Center | Corporate Officer/Principal | ||
Tango Therapeutics Sub, Inc.
 Tango Therapeutics Sub, Inc. BiotechnologyHealth Technology Tango Therapeutics, Inc. develops transformational new drugs for cancer patients. The company was founded by Alan Ashworth, Jos? Baselga, Levi Garraway, Timothy K. Lu, Antoni Ribas and William G. Kaelin, Jr. in 2017 and is headquartered in Cambridge, MA. | Biotechnology | Founder |
Statistieken
Internationaal
| Verenigde Staten | 47 |
| Spanje | 3 |
| Zwitserland | 2 |
| Nederland | 2 |
Sectoraal
| Health Technology | 30 |
| Consumer Services | 15 |
| Finance | 5 |
| Commercial Services | 2 |
| Health Services | 2 |
Operationeel
| Director/Board Member | 112 |
| Corporate Officer/Principal | 50 |
| Independent Dir/Board Member | 43 |
| Director of Finance/CFO | 25 |
| Chief Tech/Sci/R&D Officer | 24 |
Sterkste connecties
| Insiders | |
|---|---|
| Clarence Machado | 30 |
| Kathryn Falberg | 30 |
| Terry Rosen | 19 |
| Jennifer Jarrett | 18 |
| Juan Jaen | 16 |
| Antoni Ribas | 15 |
| Andrew Perlman | 14 |
| Yasunori Kaneko | 13 |
| David Lacey | 12 |
| Merdad Parsey | 11 |
| Johanna Mercier | 9 |
| Steve Young | 8 |
| Linda Higgins | 8 |
| Alexander Azoy | 8 |
| Robert Goeltz | 7 |
- Beurs
- Insiders
- Nicole Lambert
- Bedrijfsconnecties
